M&As this week: Guanhao Biotech, Arterium Corporation
Biotechnology company Guanhao Biotech has announced its acquirement of a 5% stake within a pharmaceutical company based in Beijing, China.
Biotechnology company Guanhao Biotech has announced its acquirement of a 5% stake within a pharmaceutical company based in Beijing, China.
The company expects the acquisition to cost up to $2.4m.
Arterium Corporation has acquired Marifarm, proizvodnja in storitve d.o.o. from Nova KBM for a purchase consideration of $7.54m.
The acquisition enables the acquirer and the acquired companies to strengthen their pharmaceutical research and development (R&D) and production capabilities.